Volume | 798,255 |
|
|||||
News | - | ||||||
Day High | 0.496 | Low High |
|||||
Day Low | 0.417551 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
IGC Pharma Inc | IGC | AMEX | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.421 | 0.417551 | 0.496 | 0.458 | 0.43 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
1,955 | 798,255 | US$ 0.453625 | US$ 362,108 | - | 0.2501 - 0.9099 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:52:55 | 2 | US$ 0.48 | USD |
IGC Pharma Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
29.32M | 63.73M | - | 911k | -11.51M | -0.18 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
IGC Pharma News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IGC Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.4857 | 0.508 | 0.413 | 0.4563085 | 496,259 | -0.0057 | -1.17% |
1 Month | 0.42 | 0.9099 | 0.40 | 0.5712647 | 1,712,625 | 0.06 | 14.29% |
3 Months | 0.289 | 0.9099 | 0.27 | 0.4796882 | 941,736 | 0.191 | 66.09% |
6 Months | 0.2992 | 0.9099 | 0.2501 | 0.434019 | 575,584 | 0.1808 | 60.43% |
1 Year | 0.358 | 0.9099 | 0.2501 | 0.4133209 | 390,193 | 0.122 | 34.08% |
3 Years | 1.62 | 4.65 | 0.2501 | 1.77 | 1,079,098 | -1.14 | -70.37% |
5 Years | 1.27 | 4.65 | 0.2501 | 1.96 | 1,929,930 | -0.79 | -62.20% |
IGC Pharma Description
India Globalization Capital Inc is an investment holding company. The company's operating segment includes Infrastructure and Life Sciences. It generates maximum revenue from the Life Sciences segment. The Infrastructure Business segment involves the execution of construction contracts, the rental of heavy construction equipment, and the purchase and resale of physical commodities used in infrastructure. The Life Sciences Segment includes biopharmaceuticals and Over the Counter Products Geographically, it derives a majority of revenue from Hong Kong and also has a presence in India. |